Impact of centralised reconstitution of biological medicines on the amount and costs of medicine waste
Centralisation may reduce the amount and costs of medicine waste. However, other associated factors should also be considered, such as transport and storage of ready-to-administer medicines, personnel costs and the impact on the quality and safety of care.
Authors
- Hanna M. Tolonen (ORCID: https://orcid.org/0000-0002-6824-7566)
- Kaisa Vaarala
- Sanna Eestilä (ORCID: https://orcid.org/0009-0007-8138-194X)
- Mervi Rantsi
Institutions
- University of Helsinki (FI)
- University of Eastern Finland (FI)
- Helsinki University Hospital (FI)
- Hospital District of Helsinki and Uusimaa (FI)
Publication Details
- Journal
- European Journal of Hospital Pharmacy
- Published
- 2025-04-17
- DOI
- https://doi.org/10.1136/ejhpharm-2024-004382
- Primary Topic
- Safe Handling of Antineoplastic Drugs
- Type
- article
- Field-Weighted Citation Impact
- 0.00